Latest News about financial results
Recent news which mentions financial results
Irwin Naturals Revenue Sluggish In Q2, Net Loss Grows YOY
August 28, 2023
Tickers
IWINF
From Benzinga
This Canadian Co. Said Farewell To Cannabis, Stock Surges On Heels Of Q1 Earnings Report
August 18, 2023
Tickers
NEPT
From Benzinga
Canadian Cannabis Producer Reports YoY Revenue Spike In Q2, Earnings Show Stable Growth As Demand Grows
August 17, 2023
Tickers
DBCCF
From Benzinga
$21.8M Revenue For NASDAQ-Listed Psychedelics Ancillary Company Societal CDMO's Q2 2023
August 16, 2023
Tickers
SCTL
From Benzinga
Cresco Labs Reports Slight Sequential Improvement In Q2, YoY Drop In Revenue And Gross Profit As Net Loss Grows
August 16, 2023
From Benzinga
Filament Health Shares Q1 2023 Financials, Material Uncertainties Upon Securing Additional Financing
August 15, 2023
From Benzinga
Mydecine Releases Q2 2023: Developer Of Smoke Cessation Psilocybin Prodrugs & MDMA Analogs
August 15, 2023
Tickers
MYCOF
From Benzinga
Canadian Cannabis Producer Reports Revenue Spike And Improved Margins In Q2, But What About Net Loss?
August 15, 2023
Tickers
AVCNF
From Benzinga
Cybin's Q1 2023 Financials, Deuterated Psychedelics Moving 'Steadily' Through The Clinic
August 14, 2023
Tickers
CYBN
From Benzinga
Enveric's Q2 2023 Financials Show Immediate Need For Budget-Slimming Toward A Clinical-Staged 2024
August 14, 2023
Tickers
ENVB
From Benzinga
Cannabis Real Estate Firm's Q2 Earnings Results Signal Steady Growth, Here's What You Need To Know
August 14, 2023
Tickers
ZDPY
From Benzinga
IM Cannabis Stock Drops On Q2 Earnings, CEO Touts Strategic Decisions That Led To 'Sustainable Profitability'
August 14, 2023
Tickers
IMCC
From Benzinga
Columbia Care: Q2 Report Reveals Profits In East Coast Market But This Was Before Failed Sean Diddy Mega Merger
August 14, 2023
From Benzinga
Atai's Q2 2023 Plus Clinical Data On Ibogaine-Opioid Study, Pipeline's Psilocybin, DMT, Ketamine & MDMA
August 10, 2023
From Benzinga
MindMed's Q2 2023: One Of Biggest Players In The Space Sustains Faith In LSD's Multiple Path Ahead
August 07, 2023
Tickers
MNMD
From Benzinga
COMPASS Pathways Q2 2023: $148.2M Cash Position, Steady Quarter And 'Strong Progress Across The Business'
August 03, 2023
From Benzinga
Increased Production & Retail Sales For Magic Truffles: Red Light Holland Balances 2023 Financial Results
July 31, 2023
Tickers
TRUFF
From Benzinga
From Benzinga
Jack In The Box Partnership Helps Weedmaps Report Positive Q1 Earnings Despite Revenue Decrease
May 10, 2023
Tickers
MAPS
From Benzinga
Mydecine: 2022 Financials & Business Update By Next-Gen Psychedelics Producer, Smoke Cessation Trial And More
April 03, 2023
Tickers
MYCOF
From Benzinga
Filament Health: 2022 Financials And Operational Highlights From Creator Of The Ayahuasca Pill
April 03, 2023
From Benzinga
From Benzinga
MindMed Reports Full-Year 2022 Financial Results, Highlighting Anxiety & Autism Studies
March 10, 2023
Tickers
MNMD
From Benzinga
Braxia Scientific's Q3 2023 Finances, Update On Upcoming Acquisition With Irwin Naturals
March 02, 2023
From Benzinga
Field Trip H&W Closes Q3 2023 On Material Uncertainty, Need To Lower Costs & Adapt To New Regulations
March 01, 2023
Tickers
FTHWF
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.